Pharmaceutical industry: innovation and developments
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Hauppauge, N.Y.
Nova Science
c2011
|
| Schriftenreihe: | Business issues, competition and entrepreneurship series
Pharmacology-research, safety testing, and regulation series |
| Schlagworte: | |
| Beschreibung: | Includes bibliographical references and index |
| Beschreibung: | ix, 182 p. |
| ISBN: | 9781621004394 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV044089221 | ||
| 003 | DE-604 | ||
| 005 | 20180808 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 170217s2011 |||| o||u| ||||||eng d | ||
| 020 | |a 9781621004394 |c Online |9 978-1-62100-439-4 | ||
| 035 | |a (ZDB-30-PAD)EBC3021409 | ||
| 035 | |a (ZDB-89-EBL)EBL3021409 | ||
| 035 | |a (OCoLC)750642412 | ||
| 035 | |a (DE-599)BVBBV044089221 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 082 | 0 | |a 615/.19 |2 22 | |
| 245 | 1 | 0 | |a Pharmaceutical industry |b innovation and developments |c David A. Mancuso and Isobel M. Grenada, editors |
| 264 | 1 | |a Hauppauge, N.Y. |b Nova Science |c c2011 | |
| 300 | |a ix, 182 p. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Business issues, competition and entrepreneurship series | |
| 490 | 0 | |a Pharmacology-research, safety testing, and regulation series | |
| 500 | |a Includes bibliographical references and index | ||
| 505 | 0 | |a Authorized generic pharmaceuticals : effects on innovation / John R. Thomas -- Authorized generics : an interim report / FTC -- Remarks of J. Thomas Rosch, Commissioner, Federal Trade Commission, before the World Generic Medicine Congress, hearing on "pay-for-delay settlements, authorized generics, and follow-on biologies : thoughts on the how competition law can best protect consumer welfare in the pharmaceutical context" -- Federal R&D, drug discovery, and pricing : insights from the NIH-university-industry relationship / Wendy H. Schacht -- Pharmaceutical R&D and the evolving market for prescription drugs / CBO -- Federal taxation of the drug industry and its effects on new drug development / Gary Guenther -- Pharmaceutical patent litigation settlements : implications for competition and innovation / John R. Thomas -- FDA's authority to regulate drug compounding : a legal analysis / Jennifer Staman -- Promotional spending for prescription drugs / CBO. | |
| 650 | 4 | |a Recht | |
| 650 | 4 | |a Drug development | |
| 650 | 4 | |a Pharmaceutical industry | |
| 650 | 4 | |a Drugs |x Law and legislation | |
| 700 | 1 | |a Mancuso, David A. |e Sonstige |4 oth | |
| 700 | 1 | |a Grenada, Isobel M. |e Sonstige |4 oth | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, Hardcover |z 978-1-61209-394-9 |
| 912 | |a ZDB-30-PAD |a ZDB-30-PBE | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-029496066 | ||
Datensatz im Suchindex
| _version_ | 1804177141139505152 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV044089221 |
| collection | ZDB-30-PAD ZDB-30-PBE |
| contents | Authorized generic pharmaceuticals : effects on innovation / John R. Thomas -- Authorized generics : an interim report / FTC -- Remarks of J. Thomas Rosch, Commissioner, Federal Trade Commission, before the World Generic Medicine Congress, hearing on "pay-for-delay settlements, authorized generics, and follow-on biologies : thoughts on the how competition law can best protect consumer welfare in the pharmaceutical context" -- Federal R&D, drug discovery, and pricing : insights from the NIH-university-industry relationship / Wendy H. Schacht -- Pharmaceutical R&D and the evolving market for prescription drugs / CBO -- Federal taxation of the drug industry and its effects on new drug development / Gary Guenther -- Pharmaceutical patent litigation settlements : implications for competition and innovation / John R. Thomas -- FDA's authority to regulate drug compounding : a legal analysis / Jennifer Staman -- Promotional spending for prescription drugs / CBO. |
| ctrlnum | (ZDB-30-PAD)EBC3021409 (ZDB-89-EBL)EBL3021409 (OCoLC)750642412 (DE-599)BVBBV044089221 |
| dewey-full | 615/.19 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615/.19 |
| dewey-search | 615/.19 |
| dewey-sort | 3615 219 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02362nmm a2200409zc 4500</leader><controlfield tag="001">BV044089221</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20180808 </controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">170217s2011 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781621004394</subfield><subfield code="c">Online</subfield><subfield code="9">978-1-62100-439-4</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-30-PAD)EBC3021409</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-89-EBL)EBL3021409</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)750642412</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044089221</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.19</subfield><subfield code="2">22</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Pharmaceutical industry</subfield><subfield code="b">innovation and developments</subfield><subfield code="c">David A. Mancuso and Isobel M. Grenada, editors</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Hauppauge, N.Y.</subfield><subfield code="b">Nova Science</subfield><subfield code="c">c2011</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">ix, 182 p.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Business issues, competition and entrepreneurship series</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Pharmacology-research, safety testing, and regulation series</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Authorized generic pharmaceuticals : effects on innovation / John R. Thomas -- Authorized generics : an interim report / FTC -- Remarks of J. Thomas Rosch, Commissioner, Federal Trade Commission, before the World Generic Medicine Congress, hearing on "pay-for-delay settlements, authorized generics, and follow-on biologies : thoughts on the how competition law can best protect consumer welfare in the pharmaceutical context" -- Federal R&D, drug discovery, and pricing : insights from the NIH-university-industry relationship / Wendy H. Schacht -- Pharmaceutical R&D and the evolving market for prescription drugs / CBO -- Federal taxation of the drug industry and its effects on new drug development / Gary Guenther -- Pharmaceutical patent litigation settlements : implications for competition and innovation / John R. Thomas -- FDA's authority to regulate drug compounding : a legal analysis / Jennifer Staman -- Promotional spending for prescription drugs / CBO.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Recht</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug development</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Law and legislation</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mancuso, David A.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Grenada, Isobel M.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Hardcover</subfield><subfield code="z">978-1-61209-394-9</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-30-PAD</subfield><subfield code="a">ZDB-30-PBE</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029496066</subfield></datafield></record></collection> |
| id | DE-604.BV044089221 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:43:21Z |
| institution | BVB |
| isbn | 9781621004394 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029496066 |
| oclc_num | 750642412 |
| open_access_boolean | |
| physical | ix, 182 p. |
| psigel | ZDB-30-PAD ZDB-30-PBE |
| publishDate | 2011 |
| publishDateSearch | 2011 |
| publishDateSort | 2011 |
| publisher | Nova Science |
| record_format | marc |
| series2 | Business issues, competition and entrepreneurship series Pharmacology-research, safety testing, and regulation series |
| spelling | Pharmaceutical industry innovation and developments David A. Mancuso and Isobel M. Grenada, editors Hauppauge, N.Y. Nova Science c2011 ix, 182 p. txt rdacontent c rdamedia cr rdacarrier Business issues, competition and entrepreneurship series Pharmacology-research, safety testing, and regulation series Includes bibliographical references and index Authorized generic pharmaceuticals : effects on innovation / John R. Thomas -- Authorized generics : an interim report / FTC -- Remarks of J. Thomas Rosch, Commissioner, Federal Trade Commission, before the World Generic Medicine Congress, hearing on "pay-for-delay settlements, authorized generics, and follow-on biologies : thoughts on the how competition law can best protect consumer welfare in the pharmaceutical context" -- Federal R&D, drug discovery, and pricing : insights from the NIH-university-industry relationship / Wendy H. Schacht -- Pharmaceutical R&D and the evolving market for prescription drugs / CBO -- Federal taxation of the drug industry and its effects on new drug development / Gary Guenther -- Pharmaceutical patent litigation settlements : implications for competition and innovation / John R. Thomas -- FDA's authority to regulate drug compounding : a legal analysis / Jennifer Staman -- Promotional spending for prescription drugs / CBO. Recht Drug development Pharmaceutical industry Drugs Law and legislation Mancuso, David A. Sonstige oth Grenada, Isobel M. Sonstige oth Erscheint auch als Druck-Ausgabe, Hardcover 978-1-61209-394-9 |
| spellingShingle | Pharmaceutical industry innovation and developments Authorized generic pharmaceuticals : effects on innovation / John R. Thomas -- Authorized generics : an interim report / FTC -- Remarks of J. Thomas Rosch, Commissioner, Federal Trade Commission, before the World Generic Medicine Congress, hearing on "pay-for-delay settlements, authorized generics, and follow-on biologies : thoughts on the how competition law can best protect consumer welfare in the pharmaceutical context" -- Federal R&D, drug discovery, and pricing : insights from the NIH-university-industry relationship / Wendy H. Schacht -- Pharmaceutical R&D and the evolving market for prescription drugs / CBO -- Federal taxation of the drug industry and its effects on new drug development / Gary Guenther -- Pharmaceutical patent litigation settlements : implications for competition and innovation / John R. Thomas -- FDA's authority to regulate drug compounding : a legal analysis / Jennifer Staman -- Promotional spending for prescription drugs / CBO. Recht Drug development Pharmaceutical industry Drugs Law and legislation |
| title | Pharmaceutical industry innovation and developments |
| title_auth | Pharmaceutical industry innovation and developments |
| title_exact_search | Pharmaceutical industry innovation and developments |
| title_full | Pharmaceutical industry innovation and developments David A. Mancuso and Isobel M. Grenada, editors |
| title_fullStr | Pharmaceutical industry innovation and developments David A. Mancuso and Isobel M. Grenada, editors |
| title_full_unstemmed | Pharmaceutical industry innovation and developments David A. Mancuso and Isobel M. Grenada, editors |
| title_short | Pharmaceutical industry |
| title_sort | pharmaceutical industry innovation and developments |
| title_sub | innovation and developments |
| topic | Recht Drug development Pharmaceutical industry Drugs Law and legislation |
| topic_facet | Recht Drug development Pharmaceutical industry Drugs Law and legislation |
| work_keys_str_mv | AT mancusodavida pharmaceuticalindustryinnovationanddevelopments AT grenadaisobelm pharmaceuticalindustryinnovationanddevelopments |